Dr. Hemavarna Tiruvury, MD

Dr. Tiruvury practices at Raritan Bay Medical Center in Perth Amboy, New Jersey, part of Hackensack Meridian Health.

Dr. Tiruvury's NPI, 1942436340, was assigned on June 1, 2009. Dr. Tiruvury holds New Jersey license 25MA08847000.

Dr. Tiruvury's primary practice is Raritan Bay Medical Center, at 530 New Brunswick Ave, Perth Amboy, NJ 08861 in Middlesex County. The practice phone is (732) 324-5000. Dr. Tiruvury also practices at Raritan Bay Medical Center, 531 New Brunswick Ave, Perth Amboy, NJ 08861.

Dr. Tiruvury's primary practice is Raritan Bay Medical Center in Perth Amboy, New Jersey, part of Hackensack Meridian Health. Dmand AI also links Dr. Tiruvury to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tiruvury practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Tiruvury's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Tiruvury is licensed in New Jersey.

CMS data shows 913 Medicare services from Dr. Tiruvury across 2 procedure codes in 2024, for 177 Medicare patients. Medicare paid $68,521 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 177 Medicare patients who saw Dr. Tiruvury in 2024. The largest group is 75 to 84, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tiruvury's median patient age at 74, with 45% women.

In 2024, Dr. Tiruvury wrote 20 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $666 in total drug cost. In 2022, CMS named 47 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tiruvury for performance year 2024, reported as part of a group. Dr. Tiruvury accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Tiruvury, published from 2010 to 2011. Dr. Tiruvury's most frequent co-authors are Mohamed Erritouni, MD, Brian D. Johnston, MD and Wehbeh A. Wehbeh, MD.

CMS Open Payments shows 2 general payments to Dr. Tiruvury from 2 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $15.